In an embodiment, a sinus treatment apparatus includes a current generation circuit and first and second electrodes operatively coupled to the current generation circuit. The first electrode is configured to apply electric current to a treatment location on a skin surface of the user superjacent to a targeted anatomical structure coupled to the user's sinus. The second electrode is configured to provide a current return path to the current generation circuit from a second location on the surface of the user medial to the user's hand. In an embodiment, a method of using the sinus treatment apparatus includes receiving a return current through the user's body from a location other than the user's palm.

An electrode device for use in delivery of electrical pulses to a desired tissue of a mammal. The electrode device comprises a handle portion comprising first second electrode connections, and first and second needle electrodes comprising a respective first and second attachment end. Each one of the first and second electrode connections is configured with an inner electrode position and an outer electrode position, wherein the inner and outer electrode positions are electrically conducting. Further, each one of the first and second attachment ends is configured with an insulating part configured to electrically insulate one out of the inner electrode position and the outer electrode position when located therein, and configured with an electrically conducting part configured to conduct current supplied to the other one out of the inner electrode position or the outer electrode position when located therein.

A neurostimulation system is disclosed for providing treatment to a patient during a therapy session. The neurostimulation system includes a neurostimulator for transmitting magnetic or electrical signals based upon a treatment program. A programmer is connected to the neurostimulator to set a treatment session parameter value to calculate a therapy compliance value. A compliance module is connected to the neurostimulator and the programmer to calculate and store a therapy compliance value. A control module is connected to the compliance module, the programmer and the neurostimulator and determines whether the therapy compliance value is within a range of the treatment program. The neurostimulator transmits electrical or magnetic signals to the patient in a treatment session only if the therapy compliance value meets a compliance criteria.

A neuromodulation system includes a conductive element, a magnetic field generator, a power module and a computer processor. The conductive element located internal a patient's body. At least a portion of the conductive element is positioned adjacent to a target tissue. The magnetic field generator is positioned external to the patient's body. The magnetic field generator generates a time varying magnetic field for inducing stimulation of the target tissue in combination with the conductive element to produce stimulation that is larger than that which would occur in the absence of the conductive element. The power module supplies power to the magnetic field generator. The computer processor controls the time varying magnetic field provided by the magnetic field generator according to at least one set of stimulation parameters.

A device for treating human keratinous material, in particular with the aid of an electric current. The device includes a reservoir containing a composition, in particular cosmetic or dermatological, to be applied to the keratinous material, and an end fitting for the application of the composition contained in the reservoir, the end fitting comprising a plurality of application members and a distributor. The distributor includes at least one storage cavity for the composition and supply orifices to conduct the composition from the storage cavity or cavities to the application members, and the distributor being configured so that the flow rate of the composition arriving at the application members is identical to within 20% for at least two application members, better for each application member.

Skin treatment device by application of plasma to a skin, the device includes: a body having a handle; and an electrode unit generating an atmospheric pressure plasma by application of electric power, wherein first and second grounds are provided on two opposite sides of the handle, respectively, wherein the electrode unit is detachably attached to a mounting portion recessed from one surface of the body, wherein the electrode unit comprises: a first film, a second film, and a third film laminated together; and a first conductor disposed between the first and second films, and a second conductor disposed between the second and third films, such that a dielectric barrier discharge is generated between the first and the second conductors.

There is disclosed a system for providing transcutaneous electrical stimulation to the vagus nerve of an individual comprising: an electrode unit mountable within the auricle of the individual and having at least a first electrode and a second electrode for applying the transcutaneous electrical stimulation at the cymba conchae and the tragus of the individual's auricle, and a controller for controlling the transcutaneous electrical impulse delivered by each of the first electrode and second electrode.

A cosmetic device according to an embodiment of the present disclosure comprises: a main body; a head module that is detachable from the main body; a control unit for recognizing the head module mounted to the main body; and a communication unit for transmitting information about the recognized head module to a mobile terminal. The control unit can control the operation of the head module mounted to the main body differently according to the information received from the mobile terminal.

Apparatuses, systems and methods are provided that may include a system for patient monitoring and defibrillation. The system may include at least two defibrillation electrodes. The system may further include a first unit for physiological monitoring of a patient, including ECG monitoring circuitry for monitoring ECG of the patient. The first unit may store CPR chest compression data. The system may further include a second unit, separate from the first unit, which may communicatively couple with the first unit, for providing defibrillation pulses to the patient. The second unit may include a processor, communicatively coupled with the at least two defibrillation electrodes, for providing defibrillation pulses to the patient via the at least two defibrillation electrodes.

Systems and methods are described for functional brain mapping using neuronavigational equipment and additional features. For example, some implementations described combine novel cortical stimulator tools with stereotactic navigation for three-dimensional position tracking of the cortical stimulator tools. In some implementations, the systems and methods described herein can be used on an awake patient. In some implementations, the systems and methods described herein can be used on a patient that is asleep, via motor evoked potentials (MEPs), phase reversal, or electromyography (EMG) monitoring. Accordingly, in some cases sensory and language regions of the brain can be identified in addition to motor regions.